The Predictive Factors of Malignancy in Follicular Lesion of Undeterminated Significance
Öz
Anahtar Kelimeler
Kaynakça
- 1. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-214.
- 2. Cibas ES and Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159-65.
- 3. Wang HH. Reporting thyroid fine‐needle aspiration: literature review and a proposal. Diagn Cytopathol. 2006;34(1):67-76.
- 4. Ho AS, Sarti EE, Jain KS, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid, 2014;24(5):832-9.
- 5. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach?. Am J Clin Pathol. 2011;135(5):770-5.
- 6. Horne MJ, Chhieng DC, Theoharis C, et al. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two‐tier sub‐classification. Diagn. Cytopathol. 2012;40(5):410-5.
- 7. Cakir B, Bilginer M, Ozdemir D, et al. Hemithyroidectomy Seems to be a Reasonable Initial Surgical Approach in Patients with Cytological Bethesda Category III Thyroid Nodules: An Institutional Experience. Turk J Endocrinol Metab. 2018;22(2):57-63.
- 8. Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression. John Wiley & Sons, 2013.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Cerrahi
Bölüm
Araştırma Makalesi
Yazarlar
Samet Şahin
*
0000-0003-0748-3458
Türkiye
Yunus Yuksek
0000-0003-0442-8410
Türkiye
Tanju Tütüncü
0000-0001-9058-465X
Türkiye
Yayımlanma Tarihi
10 Nisan 2023
Gönderilme Tarihi
22 Aralık 2021
Kabul Tarihi
12 Ağustos 2022
Yayımlandığı Sayı
Yıl 2023 Cilt: 10 Sayı: 1